These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16469994)

  • 1. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis 1.
    Caccialanza R; Palladini G; Klersy C; Cena H; Vagia C; Cameletti B; Russo P; Lavatelli F; Merlini G
    Am J Clin Nutr; 2006 Feb; 83(2):350-4. PubMed ID: 16469994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment.
    Caccialanza R; Palladini G; Klersy C; Cereda E; Bonardi C; Cameletti B; Quarleri L; Montagna E; Foli A; Milani P; Lavatelli F; Marena C; Merlini G
    JPEN J Parenter Enteral Nutr; 2014 Sep; 38(7):891-4. PubMed ID: 24072737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis.
    Caccialanza R; Palladini G; Klersy C; Cereda E; Bonardi C; Cameletti B; Montagna E; Russo P; Foli A; Milani P; Lavatelli F; Merlini G
    Ann Hematol; 2012 Mar; 91(3):399-406. PubMed ID: 21826471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis.
    Caccialanza R; Cereda E; Klersy C; Milani P; Cappello S; Martinelli V; Turri A; Basset M; Borioli V; Nuvolone M; Caraccia M; Lavatelli F; Masi S; Lobascio F; Foli A; Merlini G; Palladini G
    Amyloid; 2020 Sep; 27(3):168-173. PubMed ID: 32212933
    [No Abstract]   [Full Text] [Related]  

  • 5. Nutritional counseling improves quality of life and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis.
    Caccialanza R; Palladini G; Cereda E; Bonardi C; Milani P; Cameletti B; Quarleri L; Cappello S; Foli A; Lavatelli F; Klersy C; Merlini G
    Nutrition; 2015 Oct; 31(10):1228-34. PubMed ID: 26250487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of left atrial function in systemic light-chain amyloidosis: a cardiac magnetic resonance study.
    Mohty D; Boulogne C; Magne J; Varroud-Vial N; Martin S; Ettaif H; Fadel BM; Bridoux F; Aboyans V; Damy T; Jaccard A
    Eur Heart J Cardiovasc Imaging; 2016 Sep; 17(9):961-9. PubMed ID: 27194782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGE Provides Incremental Prognostic Information Over Serum Biomarkers in AL Cardiac Amyloidosis.
    Boynton SJ; Geske JB; Dispenzieri A; Syed IS; Hanson TJ; Grogan M; Araoz PA
    JACC Cardiovasc Imaging; 2016 Jun; 9(6):680-6. PubMed ID: 27209101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum prealbumin: an independent marker of short-term energy intake in the presence of multiple-organ disease involvement.
    Caccialanza R; Palladini G; Klersy C; Cereda E; Bonardi C; Quarleri L; Vadacca G; Albertini R; Merlini G
    Nutrition; 2013 Mar; 29(3):580-2. PubMed ID: 23298969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of nutritional status in immunoglobulin light chain amyloidosis.
    Sattianayagam PT; Lane T; Fox Z; Petrie A; Gibbs SD; Pinney JH; Risom SS; Rowczenio DM; Wechalekar AD; Lachmann HJ; Gilbertson JA; Hawkins PN; Gillmore JD
    Haematologica; 2013 Jan; 98(1):136-40. PubMed ID: 22983575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosis.
    Palladini G; Campana C; Klersy C; Balduini A; Vadacca G; Perfetti V; Perlini S; Obici L; Ascari E; d'Eril GM; Moratti R; Merlini G
    Circulation; 2003 May; 107(19):2440-5. PubMed ID: 12719281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype.
    Driggin E; Helmke S; De Los Santos J; Teruya S; Guadalupe S; Goldsmith J; Maurer MS
    Amyloid; 2020 Jun; 27(2):73-80. PubMed ID: 31825676
    [No Abstract]   [Full Text] [Related]  

  • 13. Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis.
    Grigoletti SS; Zuchinali P; Lemieux-Blanchard É; Béchard S; Lemieux B; Ribeiro PAB; Tournoux F
    Curr Probl Cancer; 2022 Jun; 46(3):100833. PubMed ID: 35101705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistent multiple myeloma or increased bone marrow plasma cells define equally high-risk populations in patients with immunoglobulin light chain amyloidosis.
    Kourelis TV; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Zeldenrust S; Leung N; Kyle RA; Russell S; Dingli D; Lust JA; Lin Y; Kapoor P; Rajkumar SV; McCurdy A; Dispenzieri A
    J Clin Oncol; 2013 Dec; 31(34):4319-24. PubMed ID: 24145344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
    Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
    JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pericardial Effusion and Multiple Organ Involvement Are Independent Predictors of Mortality in Patients with Systemic Light Chain Amyloidosis.
    Yuda S; Hayashi T; Yasui K; Muranaka A; Ohnishi H; Hashimoto A; Ishida T; Tsuchihashi K; Shinomura Y; Watanabe N; Miura T
    Intern Med; 2015; 54(15):1833-40. PubMed ID: 26234222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience.
    Lim AY; Lee JH; Jung KS; Gwag HB; Kim DH; Kim SJ; Lee GY; Kim JS; Kim HJ; Lee SY; Lee JE; Jeon ES; Kim K
    Korean J Intern Med; 2015 Jul; 30(4):496-505. PubMed ID: 26161016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone.
    Bochtler T; Hegenbart U; Kunz C; Benner A; Seckinger A; Dietrich S; Granzow M; Neben K; Goldschmidt H; Ho AD; Hose D; Jauch A; Schönland SO
    Amyloid; 2014 Mar; 21(1):9-17. PubMed ID: 24455967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geriatric nutritional risk index as a nutritional and survival risk assessment tool in stable outpatients with systolic heart failure.
    Sargento L; Vicente Simões A; Rodrigues J; Longo S; Lousada N; Palma Dos Reis R
    Nutr Metab Cardiovasc Dis; 2017 May; 27(5):430-437. PubMed ID: 28438373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study.
    Migrino RQ; Harmann L; Christenson R; Hari P
    Heart Vessels; 2014 Nov; 29(6):793-800. PubMed ID: 24141988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.